Recent Finacing
Recent Raise
Aadi Bioscience is a clinical-stage biopharmaceutical company developing ABI-009 (nab‑rapamycin), conducting an FDA‑agreed phase II PEComa registration trial and additional phase I/II programs in pulmonary hypertension, bladder, and pediatric cancers.
